[Neuraminidase inhibitors are effective in influenza---if administered quickly after the debut or as prophylaxis to infected persons].
Malmvall
Bo-Eric
BE
Institutionen för molekylär och klinisk medicin, Hälsouniversitetet i Linköping. bo-eric.malmvall@lj.se
D000081:Acetamides / Q000008:administration & dosage* / Q000009:adverse effects; D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D024882:Drug Resistance, Viral; D019317:Evidence-Based Medicine; D006146:Guanidines / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D007251:Influenza, Human / Q000188:drug therapy* / Q000517:prevention & control; D009439:Neuraminidase / Q000009:adverse effects*; D053139:Oseltamivir; D011714:Pyrans / Q000008:administration & dosage* / Q000009:adverse effects; D012307:Risk Factors; D012794:Sialic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D053243:Zanamivir
D000081:Acetamides; D006146:Guanidines; D007252:Influenza Vaccines; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir